37 results
8-K
EX-99.1
ABCL
AbCellera Biologics Inc
20 Feb 24
AbCellera Reports Full Year 2023 Business Results
4:27pm
million in 2022. Licensing revenue was $1.0 million.
Research & Development (R&D) Expenses – R&D expenses were $175.7 million, compared to $107.9
8-K
EX-99.2
ABCL
AbCellera Biologics Inc
20 Feb 24
AbCellera Reports Full Year 2023 Business Results
4:27pm
funding for our facilities, engine, and pipeline
C O PY RI G H T © A B C EL LE RA C O PY RI G H T © A B C EL LE RA 4 O U R E N G I N E . F O R W A R D I … AT E
C O PY RI G H T © A B C EL LE RA 19 FI N A N CI A LS Operating expenses reflect ongoing investments, predominantly in R&D. RESEARCH
8-K
EX-99.2
ABCL
AbCellera Biologics Inc
2 Nov 23
Results of Operations and Financial Condition
4:13pm
A LS Operating expenses reflect ongoing investments, predominantly in R&D. RESEARCH & DEVELOPMENT SALES & MARKETING GENERAL & ADMIN Operating Expenses … revenue, driven by research fees generated by the partnership business. Operating Expenses – Approximately $38 million in R&D expenses, reflecting growth
8-K
EX-99.1
y0bkhm5ah g2ewt
2 Nov 23
Results of Operations and Financial Condition
4:13pm
8-K
EX-99.1
woa5sagq qh
3 Aug 23
AbCellera Reports Q2 2023 Business Results
4:15pm
8-K
EX-99.1
luvjn76xmqqvx46ju1w
4 May 23
Results of Operations and Financial Condition
4:39pm
8-K
EX-99.1
tzxmmlb3g95 xqtieczu
8 Nov 22
AbCellera Reports Q3 2022 Business Results
4:31pm
8-K
EX-99.1
1way ecos06pq05
10 May 22
AbCellera Reports Q1 2022 Business Results
4:17pm
S-3ASR
wfixr
25 Feb 22
Automatic shelf registration
4:51pm
POS AM
8hooyg teb2r0g47xl2u
25 Feb 22
Prospectus update (post-effective amendment)
3:54pm
S-8
EX-99.4
lphny7ib8nwk mf
25 Feb 22
Registration of securities for employees
3:49pm
8-K
EX-99.1
a2pzu4ofv5g v7acze3
24 Feb 22
AbCellera Reports Full Year 2021 Business Results
5:02pm
8-K
EX-99.1
uwz4aqs 4tr
9 Nov 21
AbCellera Reports Q3 2021 Business Results
5:00pm
8-K
EX-99.1
4wka7ij9 km
12 Aug 21
AbCellera Reports Q2 2021 Business Results
5:21pm
424B3
pxl2p3 ikn6o
22 Jun 21
Prospectus supplement
4:48pm